Management of Acute Lactational Mastitis
Initial Conservative Management (First 12-24 Hours)
Start with a 1-2 day trial of conservative measures before initiating antibiotics, as 14-20% of mastitis cases resolve spontaneously and most are inflammatory rather than infectious. 1
Conservative Measures Include:
- NSAIDs for pain and inflammation control 1
- Ice application to the affected breast 1
- Continued breastfeeding or milk expression from the affected breast – this is essential for resolution and should never be interrupted 1, 2
- Avoid excessive pumping, heat application, and aggressive breast massage – these worsen inflammation by overstimulating milk production and causing tissue trauma 3
Critical Pitfall to Avoid:
Do not advise expressing and discarding breast milk, as this is counterproductive and risks worsening engorgement, blocked ducts, and mastitis progression 4. The infant can safely breastfeed from the affected breast. 2
Antibiotic Therapy (If No Improvement in 12-24 Hours)
If symptoms do not improve within 12-24 hours of conservative management, initiate narrow-spectrum antibiotics targeting Staphylococcus aureus, which causes the majority of infectious mastitis cases. 1
First-Line Antibiotic Options:
Dicloxacillin 500 mg orally four times daily is the preferred agent for methicillin-susceptible S. aureus 1, 4
OR
Cephalexin 500 mg orally four times daily is equally effective and particularly useful for penicillin-allergic patients 1, 4
- Both agents are safe during breastfeeding with minimal transfer to breast milk 1
- Typical treatment duration is 10-14 days 5
Alternative Antibiotics:
- Amoxicillin/clavulanic acid – broad-spectrum option, safe during breastfeeding 4
- Erythromycin or azithromycin – for penicillin-allergic patients, but note very low risk of infantile hypertrophic pyloric stenosis if used during first 13 days of infant life 4
MRSA Coverage (When to Escalate)
Consider MRSA-targeted therapy if:
- High local MRSA prevalence 1
- Previous MRSA infection 1
- No improvement within 48-72 hours of first-line beta-lactam antibiotics 1, 4
MRSA-Targeted Options:
- Clindamycin 300-450 mg orally three times daily (may increase GI side effects in infant) 4
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets orally twice daily – avoid in infants ≤28 days old or those with jaundice, prematurity, or G6PD deficiency due to bilirubin displacement risk 1, 4
- If using TMP-SMX, add a beta-lactam for streptococcal coverage 4
Criteria for Hospitalization and IV Antibiotics
Admit to hospital if:
- Fever with chills suggesting systemic involvement or sepsis risk 1, 2
- Worsening symptoms despite oral antibiotics 2
- Immunocompromised status 3
Inpatient IV Antibiotic Regimens:
- Vancomycin 1 g IV every 12 hours for severe MRSA or sepsis concern 4
- Cefazolin 2 g IV loading dose, then 1 g IV every 8 hours for non-severe penicillin allergy 4
- Clindamycin 600 mg IV every 8 hours as alternative MRSA coverage 4
Imaging and Abscess Evaluation
Obtain breast ultrasound if:
- Symptoms worsen or fail to improve within 48-72 hours of appropriate antibiotics 4, 3
- Palpable mass persists 3
- Immunocompromised patient 3
Breast abscess occurs in approximately 10% of mastitis cases and requires drainage (needle aspiration or surgical) in addition to antibiotics. 1, 2, 5 Breastfeeding can continue on the affected side as long as the infant's mouth does not contact purulent drainage. 2
Red Flags Requiring Urgent Evaluation
Refer urgently (within 48 hours) for imaging ± biopsy if:
- Symptoms persist beyond 1 week of appropriate antibiotics – may indicate inflammatory breast cancer 1
- Erythema occupying at least one-third of breast surface 1
- Peau d'orange appearance 1
This is particularly critical as inflammatory breast cancer can mimic mastitis, especially in non-lactating women, though it remains rare. 1
Supportive Care Throughout Treatment
- Pain management with analgesics is essential as pain exacerbates symptoms 2
- Lactation consultant referral to optimize infant latch and breastfeeding technique 5
- Emotional support and reassurance to prevent premature breastfeeding cessation 6
- Ensure access to breast pump if hospitalization causes prolonged separation from infant 2